Alerts will be sent to your verified email
Verify Email
SGL
|
STL Global
|
Skybiotech Healthcar
|
Vera Synthetic
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
29.1 % | -3.35 % | 10.07 % |
|
5yr average Equity Multiplier
|
2.68 | 1.38 | 1.24 |
|
5yr Average Asset Turnover Ratio
|
1.38 | 0.09 | 1.58 |
|
5yr Avg Net Profit Margin
|
10.25 % | -8.4 % | 5.21 % |
|
Price to Book
|
1.4 | 3.9 | 1.48 |
|
P/E
|
0.0 | 0.0 | 17.02 |
|
5yr Avg Cash Conversion Cycle
|
32.8 Days | 41.6 Days | 64.01 Days |
|
Inventory Days
|
43.14 Days | 20.62 Days | 32.13 Days |
|
Days Receivable
|
76.72 Days | 21.98 Days | 31.06 Days |
|
Days Payable
|
92.53 Days | 15.71 Days | 22.61 Days |
|
5yr Average Interest Coverage Ratio
|
15.02 | -50.28 | 996.86 |
|
5yr Avg ROCE
|
2.08 % | 0.32 % | 13.87 % |
|
5yr Avg Operating Profit Margin
|
2.11 % | -7.99 % | 8.32 % |
|
5 yr average Debt to Equity
|
1.0 | 0.2 | 0.06 |
|
5yr CAGR Net Profit
|
n/a | 126.22 % | 1.76 % |
|
5yr Average Return on Assets
|
8.13 % | -0.02 % | 8.1 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
65.76 % | 63.48 % | 68.66 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 8.33 % | 8.8 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
STL Global
|
Skybiotech Healthcar
|
Vera Synthetic
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|